This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
This news comes via Packaging Digest's sister publication Pharmaceutical & Medical Packaging News ... In May 2011, FDA approved Merck's new treatment for chronic hepatitis C (CHC), Victrelis (boceprevir). Victrelis is packaged in daily dosage bottles, with each bottle containing 12 capsules. "For Victrelis, as the medicine will be prescribed as a one-month supply, packaging in daily dosage bottles helps to keep track of product usage," explained Mark Egan, project leader, Merck Manufacturing, to PMP News. "The dose of Victrelis is 800 mg (four 200-mg capsules) three times daily (every 7-9 hours) with food [a meal or light snack]."
Click here to read the entire article at the PMP News website.